Evidence map›Paper›PMID 31501903›Full record

ArticleBrain : a journal of neurology2019

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination.

Stephanie Efthymiou, Vincenzo Salpietro, Nancy Malintan, Mallory Poncelet, Yamna Kriouile, Sara Fortuna, Rita De Zorzi, Katelyn Payne, Lindsay B Henderson, Andrea Cortese and 27 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Transcriptomic Profiling of Zebrafish Mutant forInternational journal of molecular sciences · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  17. Article
  18. Allelic heterogeneity and abnormal vesicle recycling inFrontiers in molecular neuroscience · 2024
    Article
  19. Human mutations inFrontiers in molecular neuroscience · 2024
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 16 institutions in 11 countries.

Stephanie EfthymiouDepartment of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
Vincenzo SalpietroDepartment of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
Nancy MalintanDepartment of Clinical and Experimental Epilepsy, UCL Institute of Neurology, Queen Square, London, UK.
Mallory PonceletINSERM U1051, Institut de Neurosciences de Montpellier (INM), Université de Montpellier, Montpellier, France.
Yamna KriouileUnit of Neuropediatrics and Neurometabolism, Pediatric Department 2, Rabat Children's Hospital, and Faculty of Medicine and Pharmacy of Rabat, University Mohammed V of Rabat, Morocco.
Sara FortunaDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy.
Rita De ZorziDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy.
Katelyn PayneRiley Hospital for Children, Indianapolis, Indiana, IN, USA.
Lindsay B HendersonGeneDx, Gaithersburg, MD, USA.
Andrea CorteseDepartment of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
Sateesh MaddirevulaDepartment of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Nadia AlhashmiDepartment of Genetics, College of Medicine, Sultan Qaboos University, Sultanate of Oman.
Sarah WiethoffDepartment of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
Mina RytenDepartment of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, London, UK.
Juan A BotiaDepartment of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, London, UK.
Vincenzo ProviteraDepartment of Neurology, Istituti Clinici Scientifici Maugeri IRCCS, Italy.
Markus SchuelkeDepartment of Neuropediatrics, Charité Universitätsmedizin Berlin, Germany.
Jana VandrovcovaDepartment of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
SYNAPS Study Group
Laurence WalshRiley Hospital for Children, Indianapolis, Indiana, IN, USA.
Erin TortiGeneDx, Gaithersburg, MD, USA.
Valeria IodiceDepartment of Brain Repair and Rehabilitation, Institute of Neurology, University College London, UK.
Maryam NajafiGenome Research Division, Human Genetics Department, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, The Netherlands.
Ehsan Ghayoor KarimianiGenetics Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London, Cranmer Terrace, London, UK.
Reza MaroofianGenetics Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London, Cranmer Terrace, London, UK.
Karine Siquier-PernetParis Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Nathalie BoddaertParis Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Pascale De LonlayParis Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Vincent CantagrelParis Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Mhammed AguennouzDepartment of Clinical and Experimental Medicine, University of Messina, Sicily.
Mohamed El KhorassaniUnit of Neuropediatrics and Neurometabolism, Pediatric Department 2, Rabat Children's Hospital, and Faculty of Medicine and Pharmacy of Rabat, University Mohammed V of Rabat, Morocco.
Miriam SchmidtsGenome Research Division, Human Genetics Department, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, The Netherlands.
Fowzan S AlkurayaDepartment of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Simon EdvardsonPaediatric Neurology Unit, Hadassah Medical Center, Jerusalem, Israel.
Maria NolanoDepartment of Neurology, Istituti Clinici Scientifici Maugeri IRCCS, Italy.
Jérôme DevauxINSERM U1051, Institut de Neurosciences de Montpellier (INM), Université de Montpellier, Montpellier, France.
Henry HouldenDepartment of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
National Hospital for Neurology and Neurosurgery · GBDélégation Paris 5 · FRInserm · FRMohammed V University · MARiley Hospital for Children · USAlfaisal University · SAHadassah Medical Center · ILRadboud University Nijmegen · NLUniversity of Trieste · ITCharité - Universitätsmedizin Berlin · DEHertie Institute for Clinical Brain Research · DEIstituti Clinici Scientifici Maugeri · ITKing Faisal Specialist Hospital & Research Centre · SASt George's, University of London · GBSultan Qaboos University · OMUniversity of Messina · IT

Funding

Medical Research Council G0601943Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council MR/J004758/1Medical Research Council MR/K000608/1Medical Research Council MR/L01095X/1Medical Research Council MR/N008324/1Medical Research Council MR/P008399/1Medical Research Council MR/S005021/1Medical Research Council MR/S01165X/1The Dunhill Medical Trust R605/0717Wellcome Trust
6 · The paper itself

Abstract

Axon pathfinding and synapse formation are essential processes for nervous system development and function. The assembly of myelinated fibres and nodes of Ranvier is mediated by a number of cell adhesion molecules of the immunoglobulin superfamily including neurofascin, encoded by the NFASC gene, and its alternative isoforms Nfasc186 and Nfasc140 (located in the axonal membrane at the node of Ranvier) and Nfasc155 (a glial component of the paranodal axoglial junction). We identified 10 individuals from six unrelated families, exhibiting a neurodevelopmental disorder characterized with a spectrum of central (intellectual disability, developmental delay, motor impairment, speech difficulties) and peripheral (early onset demyelinating neuropathy) neurological involvement, who were found by exome or genome sequencing to carry one frameshift and four different homozygous non-synonymous variants in NFASC. Expression studies using immunostaining-based techniques identified absent expression of the Nfasc155 isoform as a consequence of the frameshift variant and a significant reduction of expression was also observed in association with two non-synonymous variants affecting the fibronectin type III domain. Cell aggregation studies revealed a severely impaired Nfasc155-CNTN1/CASPR1 complex interaction as a result of the identified variants. Immunofluorescence staining of myelinated fibres from two affected individuals showed a severe loss of myelinated fibres and abnormalities in the paranodal junction morphology. Our results establish that recessive variants affecting the Nfasc155 isoform can affect the formation of paranodal axoglial junctions at the nodes of Ranvier. The genetic disease caused by biallelic NFASC variants includes neurodevelopmental impairment and a spectrum of central and peripheral demyelination as part of its core clinical phenotype. Our findings support possible overlapping molecular mechanisms of paranodal damage at peripheral nerves in both the immune-mediated and the genetic disease, but the observation of prominent central neurological involvement in NFASC biallelic variant carriers highlights the importance of this gene in human brain development and function.

Indexed as

AdolescentAdultAllelesAxonsCell Adhesion MoleculesChildChild, PreschoolDemyelinating DiseasesFemaleGene FrequencyHumansInfantMaleMutationMyelin SheathNerve Fibers, MyelinatedCell Adhesion MoleculesNerve Growth FactorsNFASC protein, humanProtein Isoformsneurodevelopmentneurofascinperipheral demyelination

Identifiers

PMID31501903
PMCPMC6763744
OpenAlexW2972745819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.